company background image
DIM logo

Sartorius Stedim Biotech ENXTPA:DIM Stock Report

Last Price

€178.75

Market Cap

€17.4b

7D

-3.2%

1Y

-35.4%

Updated

14 Jun, 2024

Data

Company Financials +

Sartorius Stedim Biotech S.A.

ENXTPA:DIM Stock Report

Market Cap: €17.4b

DIM Stock Overview

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

DIM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance1/6
Financial Health3/6
Dividends0/6

Sartorius Stedim Biotech S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sartorius Stedim Biotech
Historical stock prices
Current Share Price€178.75
52 Week High€287.80
52 Week Low€160.55
Beta0.63
1 Month Change-16.86%
3 Month Change-34.40%
1 Year Change-35.35%
3 Year Change-53.06%
5 Year Change27.50%
Change since IPO2,075.02%

Recent News & Updates

Recent updates

Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

May 13
Sartorius Stedim Biotech (EPA:DIM) Has A Somewhat Strained Balance Sheet

Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

Apr 21
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next

With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Apr 20
With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For

Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Feb 19
Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)

Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Dec 22
Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Dec 01
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Nov 10
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Aug 23
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

May 25
Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

May 09
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching

Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Apr 23
Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?

Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Feb 07
Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly

Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Jan 20
Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?

Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Nov 09
Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet

Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Oct 20
Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today

Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

Oct 03
Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)

We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Jul 26
We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt

Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Jul 09
Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?

Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Jun 21
Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Apr 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

Apr 03
Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock

We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Feb 24
We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit

Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Dec 04
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?

Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Aug 21
Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt

Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

May 10
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?

Shareholder Returns

DIMFR Life SciencesFR Market
7D-3.2%-2.5%-6.3%
1Y-35.4%-20.5%-2.4%

Return vs Industry: DIM underperformed the French Life Sciences industry which returned -19.6% over the past year.

Return vs Market: DIM underperformed the French Market which returned 1.8% over the past year.

Price Volatility

Is DIM's price volatile compared to industry and market?
DIM volatility
DIM Average Weekly Movement6.3%
Life Sciences Industry Average Movement5.6%
Market Average Movement4.6%
10% most volatile stocks in FR Market9.1%
10% least volatile stocks in FR Market2.6%

Stable Share Price: DIM's share price has been volatile over the past 3 months.

Volatility Over Time: DIM's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197810,493Rene Faberwww.sartorius.com

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products.

Sartorius Stedim Biotech S.A. Fundamentals Summary

How do Sartorius Stedim Biotech's earnings and revenue compare to its market cap?
DIM fundamental statistics
Market cap€17.39b
Earnings (TTM)€254.70m
Revenue (TTM)€2.72b

68.3x

P/E Ratio

6.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DIM income statement (TTM)
Revenue€2.72b
Cost of Revenue€1.53b
Gross Profit€1.18b
Other Expenses€927.00m
Earnings€254.70m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 19, 2024

Earnings per share (EPS)2.62
Gross Margin43.50%
Net Profit Margin9.38%
Debt/Equity Ratio79.5%

How did DIM perform over the long term?

See historical performance and comparison

Dividends

0.4%

Current Dividend Yield

21%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.